• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断心房颤动的抗凝治疗与 90 天内卒中与出血发生率。

Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding.

机构信息

Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Hamilton Health Sciences, Hamilton, ON, Canada.

出版信息

CJEM. 2021 May;23(3):325-329. doi: 10.1007/s43678-020-00054-y. Epub 2021 Jan 20.

DOI:10.1007/s43678-020-00054-y
PMID:33959927
Abstract

BACKGROUND

Atrial fibrillation increases the risk of stroke, which can be mitigated by anticoagulant prescription. We evaluated local emergency physician anticoagulation practice for patients discharged from the emergency department with atrial fibrillation, along with 90-day incidence of stroke and major bleeding.

METHODS

This was a health record review of patients diagnosed with new onset atrial fibrillation in two emergency departments between 2014 and 2017. We collected data on CHADS65 scores, contraindications to direct oral anticoagulant (DOAC) prescription and initiation of anticoagulation in the ED. Patient charts were reviewed for the diagnosis of stroke, transient ischemic attack (TIA), systemic embolism or major bleeding within 90 days.

RESULTS

We identified 399 patients, median age 68 (IQR 57-79), 213 (53%) male. Only 299/399 patients had an indication for anticoagulation (CHADS65-positive). Of these 299, 27 had a contraindication to or were already prescribed anticoagulation. 45/272 (17%, 95% confidence interval 12-22%) patients eligible for initiation of anticoagulation left the emergency department with a prescription for anticoagulation. During 90-day follow-up, seven patients had stroke or TIA. Four stroke/TIA patients had been eligible to start an anticoagulant but were not started, two left the emergency department with prescriptions for an anticoagulant and one patient had a contraindication to initiating anticoagulation in the emergency department. There were no major bleeding episodes.

CONCLUSION

Few eligible patients were prescribed anticoagulation and the 90-day stroke rate was high. Physicians should become familiar with the CAEP Acute AF Best Practices Checklist AF which offers guidance on anticoagulation prescription.

摘要

背景

心房颤动会增加中风的风险,中风可以通过开抗凝药物来缓解。我们评估了从急诊科出院的伴有心房颤动的患者的当地急诊医师抗凝治疗实践,以及 90 天内中风和大出血的发生率。

方法

这是对 2014 年至 2017 年期间两家急诊科新发心房颤动患者的病历回顾。我们收集了 CHADS65 评分、直接口服抗凝剂(DOAC)处方和急诊科开始抗凝的禁忌证的数据。患者病历记录了 90 天内中风、短暂性脑缺血发作(TIA)、系统性栓塞或大出血的诊断。

结果

我们确定了 399 例患者,中位年龄为 68(IQR 57-79),213 例(53%)为男性。只有 299/399 例患者有抗凝指征(CHADS65 阳性)。在这 299 例中,有 27 例有抗凝禁忌证或已开始抗凝。在 272 例符合抗凝治疗条件的患者中,有 45 例(17%,95%置信区间 12-22%)在离开急诊科时开了抗凝药处方。在 90 天随访期间,有 7 例发生中风或 TIA。4 例中风/TIA 患者符合开始抗凝治疗的条件但未开始治疗,2 例离开急诊科时开了抗凝药处方,1 例在急诊科有抗凝治疗禁忌证。没有大出血事件。

结论

有抗凝指征的患者中只有少数人开了抗凝药,90 天内中风发生率较高。医生应熟悉 CAEP 急性房颤最佳实践检查表 AF,该检查表提供了抗凝药物处方的指导。

相似文献

1
Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding.新诊断心房颤动的抗凝治疗与 90 天内卒中与出血发生率。
CJEM. 2021 May;23(3):325-329. doi: 10.1007/s43678-020-00054-y. Epub 2021 Jan 20.
2
Ninety-Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke.在急诊室因心房颤动伴新发短暂性脑缺血发作或小卒中而接受抗凝治疗的患者中,90 天内卒中或短暂性脑缺血发作复发的情况。
J Am Heart Assoc. 2023 Apr 18;12(8):e026681. doi: 10.1161/JAHA.122.026681. Epub 2023 Apr 7.
3
Anticoagulation prescription among atrial fibrillation patients managed with and without an anticoagulant initiation pathway: a cohort study.伴有和不伴有抗凝药物起始途径的房颤患者的抗凝处方:一项队列研究。
Eur J Emerg Med. 2023 Oct 1;30(5):365-370. doi: 10.1097/MEJ.0000000000001072. Epub 2023 Jun 13.
4
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.直接口服抗凝剂和华法林治疗心房颤动患者的处方模式和结局:真实世界分析。
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29.
5
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.急诊医师对房颤患者抗凝治疗启动的态度。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105474. doi: 10.1016/j.jstrokecerebrovasdis.2020.105474. Epub 2020 Nov 23.
6
Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.在心房颤动导管消融期间不间断抗凝:更新的随机对照试验荟萃分析显示,直接口服抗凝剂与维生素 K 拮抗剂在大出血和卒中方面无差异。
Acta Cardiol. 2021 May;76(3):288-295. doi: 10.1080/00015385.2020.1724689. Epub 2020 Feb 14.
7
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.伴有或不伴有既往卒中和短暂性脑缺血发作的器械检出心房颤动患者的抗凝治疗:NOAH-AFNET 6 试验。
J Am Heart Assoc. 2024 Sep 3;13(17):e036429. doi: 10.1161/JAHA.124.036429. Epub 2024 Aug 27.
8
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.医疗机构类型、抗凝药物处方模式与房颤患者的卒中风险
J Am Heart Assoc. 2018 Mar 10;7(6):e007943. doi: 10.1161/JAHA.117.007943.
9
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED).加拿大社区在急诊科应用卒中预防治疗心房颤动研究(C-CUSP ED)。
Ann Emerg Med. 2019 Apr;73(4):382-392. doi: 10.1016/j.annemergmed.2018.09.001. Epub 2018 Oct 26.
10
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.直接口服抗凝剂上市后和国家指南改变对卒中二级预防的住院推荐和抗凝药物处方的改变。
Cerebrovasc Dis. 2020;49(4):412-418. doi: 10.1159/000509416. Epub 2020 Aug 5.